BMS 6073 (Glucovance 2.5 mg / 500 mg)

Generic Name: glyburide/metformin

Pill imprint BMS 6073 has been identified as Glucovance 2.5 mg / 500 mg.

Glucovance is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glucovance 2.5 mg / 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for BMS 6073

Glucovance 2.5 mg / 500 mg BMS 6073
Glucovance 2.5 mg / 500 mg BMS 6073 Front
Glucovance 2.5 mg / 500 mg BMS 6073 Back
Glucovance
Generic Name:
glyburide/metformin
Imprint:
BMS
6073
Strength:
2.5 mg / 500 mg
Color:
Orange
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00087-6073
Inactive Ingredients:
microcrystalline cellulose
povidone
croscarmellose sodium
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
66116-0233 Medvantx Inc (repackager)
54868-4609 Physicians Total Care Inc (repackager)
68115-0158 Dispensexpress Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)